The Biotech industry is up 3.1% in the last week, with BioLineRx up 19%. In the same time, Evogene was down 6.1%. This takes the industry's 12 month performance to a gain of 6.2%. As for the next few years, earnings are expected to grow by 47% per annum.
Has the Israeli Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 26 Sep 2023 | ₪2.3b | ₪619.1m | -₪379,560,038.00 | 73.6x | -6.1x | 3.7x |
Thu, 24 Aug 2023 | ₪1.9b | ₪609.8m | -₪336,786,986.00 | 65.1x | -5.6x | 3.1x |
Sat, 22 Jul 2023 | ₪1.9b | ₪539.1m | -₪390,545,047.00 | n/a | -4.9x | 3.6x |
Mon, 19 Jun 2023 | ₪1.9b | ₪528.8m | -₪384,987,110.00 | n/a | -4.9x | 3.6x |
Wed, 17 May 2023 | ₪1.7b | ₪530.9m | -₪367,043,272.00 | n/a | -4.7x | 3.3x |
Fri, 14 Apr 2023 | ₪1.6b | ₪614.4m | -₪426,739,762.00 | 2.4x | -3.8x | 2.6x |
Sun, 12 Mar 2023 | ₪1.6b | ₪557.5m | -₪461,079,216.00 | 4.7x | -3.4x | 2.8x |
Tue, 07 Feb 2023 | ₪1.6b | ₪540.4m | -₪466,473,612.00 | 4.7x | -3.5x | 3x |
Thu, 05 Jan 2023 | ₪1.6b | ₪535.0m | -₪475,995,177.00 | 15.8x | -3.4x | 3x |
Sat, 03 Dec 2022 | ₪1.7b | ₪474.6m | -₪461,745,307.00 | 18.3x | -3.7x | 3.6x |
Mon, 31 Oct 2022 | ₪1.9b | ₪493.8m | -₪487,440,189.00 | 16.9x | -3.8x | 3.8x |
Wed, 28 Sep 2022 | ₪1.9b | ₪492.3m | -₪486,338,129.00 | 18.5x | -3.9x | 3.9x |
Fri, 26 Aug 2022 | ₪2.2b | ₪447.9m | -₪402,124,595.00 | 5.8x | -5.4x | 4.9x |
Sun, 24 Jul 2022 | ₪2.1b | ₪491.8m | -₪399,827,322.00 | 13.5x | -5.2x | 4.2x |
Tue, 21 Jun 2022 | ₪2.2b | ₪487.8m | -₪400,201,775.00 | 12.4x | -5.5x | 4.5x |
Thu, 19 May 2022 | ₪2.4b | ₪474.8m | -₪487,770,571.00 | 13.8x | -4.9x | 5.1x |
Sat, 16 Apr 2022 | ₪2.9b | ₪458.8m | -₪491,828,710.00 | 10x | -5.8x | 6.2x |
Mon, 14 Mar 2022 | ₪2.7b | ₪462.5m | -₪221,835,867.00 | 7x | -12.4x | 5.9x |
Wed, 09 Feb 2022 | ₪2.9b | ₪458.9m | -₪221,715,542.00 | 7.1x | -13.3x | 6.4x |
Fri, 07 Jan 2022 | ₪3.7b | ₪447.9m | -₪214,106,337.00 | 10.3x | -17.1x | 8.2x |
Sun, 05 Dec 2021 | ₪3.7b | ₪426.4m | -₪218,627,772.00 | 9.3x | -16.8x | 8.6x |
Tue, 02 Nov 2021 | ₪4.1b | ₪462.4m | -₪167,370,876.00 | 10x | -24.3x | 8.8x |
Thu, 30 Sep 2021 | ₪4.1b | ₪474.5m | -₪173,585,294.00 | 10.3x | -23.4x | 8.6x |
Sat, 28 Aug 2021 | ₪4.2b | ₪483.2m | -₪167,305,098.00 | 4x | -24.9x | 8.6x |
Sun, 04 Jul 2021 | ₪3.9b | ₪483.2m | -₪167,305,098.00 | 5.5x | -23.6x | 8.2x |
Wed, 07 Apr 2021 | ₪4.2b | ₪528.7m | -₪109,530,611.00 | 3x | -38x | 7.9x |
Sat, 09 Jan 2021 | ₪2.9b | ₪520.8m | -₪57,738,930.40 | 2.9x | -50.8x | 5.6x |
Fri, 02 Oct 2020 | ₪2.9b | ₪546.7m | -₪199,116,926.70 | 9.9x | -14.7x | 5.4x |
-14.7x
How does Israeli Biotech compare with similar industries?
IL Market | 1.34% | |
Healthcare | -0.18% | |
Biotech | 0.95% | |
Biotech | 0.95% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
BLRX BioLineRx | ₪0.52 | 3.2% +₪14.8m | 124.0% | PB6x | |
GFC-M G.F.C Green Fields Capital | ₪9.71 | 6.8% +₪6.3m | n/a | PE59.7x | |
PLNT PlantArc Bio | ₪4.87 | 4.2% +₪642.0k | -32.9% | PS7.3x | |
XTLB XTL Biopharmaceuticals | ₪0.036 | 2.9% +₪544.9k | -23.4% | PB1.9x | |
HDST-M HBL - Hadasit Bio-Holdings | ₪0.74 | 5.7% +₪443.5k | -72.9% | PB0.7x |